Journal of Jilin University(Medicine Edition) ›› 2023, Vol. 49 ›› Issue (5): 1243-1252.doi: 10.13481/j.1671-587X.20230518
• Research in clinical medicine • Previous Articles Next Articles
Yaqi XU,Yanyu WANG,Wenjing ZHANG,Mei HAN,Huaxia MU,Xi YANG,Weixiao BU,Zikun TAO,Yujia KONG,Fuyan SHI(
),Suzhen WANG(
)
Received:2022-11-24
Online:2023-09-28
Published:2023-10-26
Contact:
Fuyan SHI,Suzhen WANG
E-mail:shifuyan@126.com;wangsz@wfmc.edu.cn
CLC Number:
Yaqi XU,Yanyu WANG,Wenjing ZHANG,Mei HAN,Huaxia MU,Xi YANG,Weixiao BU,Zikun TAO,Yujia KONG,Fuyan SHI,Suzhen WANG. Bioinformatics analysis on screening of key genes of hepatitis B virus-related hepatocellular carcinoma and its relationship with prognosis[J].Journal of Jilin University(Medicine Edition), 2023, 49(5): 1243-1252.
Tab. 1
KEGG signaling pathway enrichment analysis on key genes"
| ID | Description | Count | P | Gene |
|---|---|---|---|---|
| hsa04110 | Cell cycle | 4 | 2.702 3E-07 | CDC20,CDK1,CCNA2,BUB1B |
| hsa05203 | Viral carcinogenesis | 3 | 0.000 149 353 | CDC20,CDK1,CCNA2 |
| hsa05166 | Human T lymphocyte leukemia virus 1 infection | 3 | 0.000 192 061 | CDC20,CCNA2,BUB1B |
| hsa04914 | Progesterone-mediated oocyte maturation | 2 | 0.001 516 381 | CDK1,CCNA2 |
| hsa04114 | Oocyte meiosis | 2 | 0.002 488 770 | CDC20,CDK1 |
| hsa04218 | Cellular senescence | 2 | 0.003 511 844 | CDK1,CCNA2 |
| 1 | BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424. |
| 2 | PETRICK J L, FLORIO A A, ZNAOR A, et al. International trends in hepatocellular carcinoma incidence, 1978-2012[J]. Int J Cancer, 2020, 147(2): 317-330. |
| 3 | RINALDI L, GUARINO M, PERRELLA A, et al. Role of liver stiffness measurement in predicting HCC occurrence in direct-acting antivirals setting: a real-life experience[J]. Dig Dis Sci, 2019, 64(10): 3013-3019. |
| 4 | GRANDHI M S, KIM A K, RONNEKLEIV-KELLY S M, et al. Hepatocellular carcinoma: from diagnosis to treatment[J]. Surg Oncol, 2016, 25(2): 74-85. |
| 5 | DING W, ZHANG Z, YE N Y, et al. Identification of key genes in the HBV-related HCC immune microenvironment using integrated bioinformatics analysis[J]. J Oncol, 2022, 2022: 2797033. |
| 6 | WANG S M, OOI L L P J, HUI K M. Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma[J]. Clin Cancer Res, 2007, 13(21): 6275-6283. |
| 7 | SZKLARCZYK D, GABLE A L, NASTOU K C,et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets[J]. Nucleic Acids Res, 2021, 49(D1): D605-D612. |
| 8 | CHIN C H, CHEN S H, WU H H, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome[J]. BMC Syst Biol, 2014, 8(): S11. |
| 9 | TANG Z F, LI C W, KANG B X, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 45(W1): W98-W102. |
| 10 | LÁNCZKY A, GYÖRFFY B. Web-based survival analysis tool tailored for medical research (KMplot): development and implementation[J]. J Med Internet Res, 2021, 23(7): e27633. |
| 11 | ASPLUND A, EDQVIST P H D, SCHWENK J M, et al. Antibodies for profiling the human proteome-The Human Protein Atlas as a resource for cancer research[J]. Proteomics, 2012, 12(13): 2067-2077. |
| 12 | YANG J D, HAINAUT P, GORES G J, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(10): 589-604. |
| 13 | SCHWEITZER A, HORN J, MIKOLAJCZYK R T, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013[J]. Lancet, 2015, 386(10003): 1546-1555. |
| 14 | REVILL P A, TU T, NETTER H J, et al. The evolution and clinical impact of hepatitis B virus genome diversity[J]. Nat Rev Gastroenterol Hepatol, 2020, 17(10): 618-634. |
| 15 | COLOTTA F, ALLAVENA P, SICA A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability[J]. Carcinogenesis, 2009, 30(7): 1073-1081. |
| 16 | HUANG X B, HE Y G, ZHENG L, et al. Identification of hepatitis B virus and liver cancer bridge molecules based on functional module network[J]. World J Gastroenterol, 2019, 25(33): 4921-4932. |
| 17 | PETTINELLI P, ARENDT B M, TETERINA A,et al.Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease[J]. PLoS One, 2018, 13(10): e0205747. |
| 18 | GAO J, WANG Z, WANG G J, et al. From hepatofibrosis to hepatocarcinogenesis: higher cytochrome P450 2E1 activity is a potential risk factor[J].Mol Carcinog, 2018, 57(10): 1371-1382. |
| 19 | OLIVEIRA P A, COLAÇO A, CHAVES R, et al. Chemical carcinogenesis[J]. An Acad Bras Cienc, 2007, 79(4): 593-616. |
| 20 | RAJAGOPALAN H, LENGAUER C. Aneuploidy and cancer[J]. Nature, 2004, 432(7015): 338-341. |
| 21 | ZHAO J, HAN S X, MA J L, et al. The role of CDK1 in apoptin-induced apoptosis in hepatocellular carcinoma cells[J]. Oncol Rep, 2013, 30(1): 253-259. |
| 22 | ITO Y, TAKEDA T, SAKON M, et al. Expression and prognostic role of cyclin-dependent kinase 1 (cdc2) in hepatocellular carcinoma[J]. Oncology, 2000,59(1): 68-74. |
| 23 | KIM D H, PARK S E, KIM M, et al. A functional single nucleotide polymorphism at the promoter region of cyclin A2 is associated with increased risk of colon, liver, and lung cancers[J]. Cancer, 2011, 117(17): 4080-4091. |
| 24 | MA Q, LIU Y M, SHANG L, et al. The FOXM1/BUB1B signaling pathway is essential for the tumorigenicity and radioresistance of glioblastoma[J]. Oncol Rep, 2017, 38(6): 3367-3375. |
| 25 | NG I O, NA J, LAI E C, et al. Ki-67 antigen expression in hepatocellular carcinoma using monoclonal antibody MIB1. A comparison with proliferating cell nuclear antigen[J]. Am J Clin Pathol, 1995, 104(3): 313-318. |
| 26 | KUO T C, CHANG P Y, HUANG S F, et al. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53[J]. Biochem Pharmacol, 2012, 83(6): 758-768. |
| 27 | HE B S, YIN J B, GONG S C, et al. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis[J]. Medicine, 2017, 96(25): e6938. |
| 28 | WU B, HU C Y, KONG L B. ASPM combined with KIF11 promotes the malignant progression of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway[J]. Exp Ther Med, 2021, 22(4): 1154. |
| 29 | JEFFERY J, SINHA D, SRIHARI S, et al. Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis[J]. Oncogene, 2016, 35(6): 683-690. |
| 30 | GASNEREAU I, BOISSAN M, MARGALL-DUCOS G, et al. KIF20A mRNA and its product MKlp2 are increased during hepatocyte proliferation and hepatocarcinogenesis[J].Am J Pathol, 2012,180(1):131-140. |
| 31 | GUIDOTTI L G, CHISARI F V. Noncytolytic control of viral infections by the innate and adaptive immune response[J]. Annu Rev Immunol, 2001, 19: 65-91. |
| 32 | THIMME R, WIELAND S, STEIGER C, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection[J]. J Virol, 2003, 77(1): 68-76. |
| 33 | YANG P Y, LI Q J, FENG Y X, et al. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma[J]. Cancer Cell, 2012, 22(3): 291-303. |
| 34 | JIN Z, SUN R, WEI H, et al. Accelerated liver fibrosis in hepatitis B virus transgenic mice: involvement of natural killer T cells[J].Hepatology,2011,53(1):219-229. |
| 35 | LI X, SU Y, HUA X, et al. Levels of hepatic Th17 cells and regulatory T cells upregulated by hepatic stellate cells in advanced HBV-related liver fibrosis[J]. J Transl Med,2017, 15(1):75. |
| 36 | KONG X, SUN R, CHEN Y, et al. γδT cells drive myeloid-derived suppressor cell-mediated CD8+ T cell exhaustion in hepatitis B virus-induced immunotolerance[J]. J Immunol,2014, 193(4):1645-1653. |
| [1] | Gengfei CAO, SHAYA·Mahati,Junpeng GU,Weizheng JI, ASIHAER·Hasimu,Weixin REN. Differences in immune microenvironment between DEB-TACE and c-TACE in treatment of hepatocellular carcinoma and mechanism of TRADD-mediated Th17 differentiation [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 764-780. |
| [2] | Xiaohui LIANG,Wenna LIU,Jianbo ZHAO. Bioinformatic analysis on PAQR3 expression in hepatocellular carcinoma and its correlations with T lymphocyte infiltration, immune checkpoint genes, and patient survival [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 781-790. |
| [3] | Zhipeng PAN,Le WANG,Weiwen HUANG,Zhen YI,Yuxuan GAO. Bioinformatics analysis and experimental validation based on screening and identification of diagnostic candidate genes of bone marrow mononuclear cells of acute myeloid leukemia patients and their impact on prognosis [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 791-805. |
| [4] | Xiqian ZHANG,Zhibo DANG,Yunan DU,Pei WU,Hang XIE,Gaofeng TAN. Inhibitory effect of Chaiqi Yigan formula on malignant biological behaviors of liver cancer HepG2 cells by regulating macrophage polarization [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 398-409. |
| [5] | Ruihan GE,Chen LI,Shengpeng WANG,Yang LU,Caixia TAN,Haotian CUI,Xinmin WANG,Le ZHANG. Bioinformatic analysis on regulatory mechanism of MAPK-Mcl-1 signaling pathway and macrophage polarization during Bacillus Calmette-Guérin infection and its experimental validation [J]. Journal of Jilin University(Medicine Edition), 2026, 52(2): 440-450. |
| [6] | Jiaxin WANG,Junwen MAO,Xuan ZHANG. Expression of natural autoantibodies against apoptosis inhibitory genes in plasma of patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 228-235. |
| [7] | Xiao LIN,Meng ZHOU,Fan LIN,Xiujuan YAO. Bioinformatics analysis and experimental validation of fatty acid metabolism-related genes in idiopathic pulmonary fibrosis tissue [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 93-104. |
| [8] | Limei WEN,Yali GUO,Wenmei MA,Taotao XUE,Ruoyu GENG,Chong MA,Xinhong ZHANG,Jianhua YANG. Bioinformatic analysis of TCGA database based on INPP4B gene expression in hepatocellular carcinoma and its experimental validation [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1618-1629. |
| [9] | Yu LIANG,Jinyu YU,Zhonggao XU,Wanning WANG. Expression characteristics of FOSB in kidney tissue from IgA nephropathy and other common kidney diseases [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1281-1292. |
| [10] | Weigao SHEN,Yuqi LIU,Jun ZHANG,Jiayu LIN,Hang CUI,Yanbo LIU. Bioinformatics analysis on effect of interleukin-33 on occurrence and development of malignant brain glioma and its experimental validation [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1318-1332. |
| [11] | Ming CHEN,Qinghua LUO,Hongguang JIN,Liang HAN. Atypical lipomatous tumor of left lower limb: A case report and literature review [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1384-1389. |
| [12] | Ziru ZHOU,Mengfei SUN,Huakun ZHANG,Shuyan SUN,Qi SUN,Feng LI,Yunzhao CHEN,Jie YU,Yuwen CAO,Xiaobin CUI. Expression of Rh family C glycoprotein in esophageal squamous carcinoma and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1019-1027. |
| [13] | Linrui XU,Yiyu ZHANG,Jiaqi CUI,Xianzhu CONG,Shuang LI,Jiayu GE,Yujia KONG,Suzhen WANG,Fuyan SHI,Jinrong WANG. Construction of diagnostic model for Alzheimer’s disease and immune analysis based on bioinformatics and machine learning [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1039-1051. |
| [14] | Xianwei JIANG,Minghang WANG,Huiru LI,Xiaosheng DONG,Yuanyuan LIU. Mendelian randomization and GEO database identification analysis based on potential therapeutic targets for chronic obstructive pulmonary disease [J]. Journal of Jilin University(Medicine Edition), 2025, 51(4): 1072-1083. |
| [15] | Han LIN,Qiuyan YANG,Jieyue ZHONG,Bolun CHEN,Wangxia TONG. Improvement effect of cordycepin on ferroptosis in HepG2 cells induced by RSL3 and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 576-589. |